All compounds sold on this site are research-grade materials intended exclusively for in-vitro laboratory research by qualified professionals.
Tesamorelin is a 44-amino-acid peptide modified so it lasts longer in the body — a synthetic version of GHRH, the hormone the body uses to trigger growth-hormone release. Lab studies have looked at how it binds the GHRH receptor, and published research literature has looked at IGF-1 and lipid-metabolism markers across several study groups.
Identity
trans-3-hexenoyl-GHRH(1-44) · CAS 901758-09-6
C221H366N72O67S · ≥99% HPLC · 10 mg · 3 mL vial
Research on tesamorelin, a synthetic 44-amino-acid analog of human growth-hormone-releasing hormone stabilised by an N-terminal trans-3-hexenoyl group, examines its activity at the pituitary GHRH receptor in pulsatile GH-axis studies. Published work in healthy adult cohorts characterises endogenous GH pulsatility, IGF-1 kinetics, and downstream hepatic markers such as FGF21, while preclinical reviews map the GH/IGF-1 axis in peripheral tissue regeneration models.
References
Reconstitution & storage
Reconstitute with bacteriostatic or sterile water to the concentration required by the researcher’s own protocol. Lyophilised: store at 2–8 °C, protected from light; refer to the lot CoA for the expiration date. Reconstituted: refrigerate at 2–8 °C and use within the researcher’s validated window; hold at −20 °C for longer-term storage.
Documentation — batch Certificate of Analysis (HPLC, third-party) provided for the lot shipped.
For Research Use Only. Not for Human or Veterinary Use. Not a drug, food, or supplement; not evaluated by the FDA; not intended for human or animal use.
